Clinical Trial Update: De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting results from Phase 2/3 trials of de novo sirolimus-based immunosuppression after liver transplantation in hepatocellular carcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: University of Alberta | Conditions: Liver Carcinoma | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2012-10-01